Osmotic Fragility and Some Hematological Implications of Chronically Administered Carbamazepine is Attenuated by Resveratrol and Vitamin E Combination

Osmotic Fragility and Some Hematological Implications of Chronically Administered Carbamazepine is Attenuated by Resveratrol and Vitamin E Combination

Introduction

Carbamazepine (CBZ) is the most frequently prescribed drug for the treatment of several forms of epilepsy; it is administered alone or in combination with other medications to treat certain types of seizures in patients with epilepsy. Its main function is reduction of sustained repetitive firing in neurones by blocking voltage-gated sodium channels. CBZ exerts its therapeutic effects through the inhibition of brain neuronal activities. It is used for the treatment of seizure disorders and trigeminal and other neuralgias [1]. This leaves the affected cells less excitable until the drug dissociates. Carbamazepine is also a GABA receptor agonist, as it has also been shown to potentiate GABA receptors made up of α1, β2, and γ2 subunits. This mechanism may contribute to its efficacy in neuropathic pain and manic-depressive illness. Laboratory research has further demonstrated that it is a serotonin releasing agent and possibly even a serotonin reuptake inhibitor [2] Previously, anti-epileptic drugs have been reported to influence decrease in haemoglobin concentration, Red Blood Cell (RBC), White Blood Cell (WBC) counts after long term antiepileptic therapy [3], while other studies have shown that carbamazepine in particular is associated with hematological changes such as leucopenia, decreased red blood cell count, decreased hemaoglobin, aplastic anemia, agranulocytosis, pancytopenia, thrombocytopenia and megaloblastic anemia [4]. It has also been reported that people treated with carbamazepine showed evidence of haematological alterations [5]. Numerous studies have examined and found that carbamazepine induces oxidative stress [6,7].

Reactive metabolite of CBZ known as arene oxide has been implicated as a mechanism for cellular damages caused by this drug [8]. Vitamin E is a lipid soluble antioxidant present in all cellular membranes protecting against lipid peroxidation. It functions as a chain-breaking antioxidant by preventing chain initiation and propagation of free radical reaction and lipid peroxidation in cellular membrane. In addition to its antioxidant function, vitamin E influences the cellular response to oxidative stress through modulation of signal-transduction pathway [9]. Vitamin E was observed to significantly reduce the levels of serum glutamate oxaloacetate transaminase, serum glutamate pyruvate transaminase and bilirubin, the markers of hepatotoxicity elevated by CBZ and increases the levels of albumin and total protein depleted by CBZ [10]. Resveratrol, also known as 3,5,4′-trihydroxystilbene, is a polyphenolic phytoalexin found in grape skin [11]. It is best known for being found at high concentrations in red wine, but is also present in small amount in other plant products [11]. It has been found to possess anti-inflammatory, anti-cancer, and antioxidant properties, as well as its ability to increase lifespan in mammals [12]. Resveratrol effectively scavenges (neutralizes) free radicals and other oxidants [13] and inhibits Low Density Lipoprotein (LDL) oxidation [14,15]. In this work, we investigated the combined effect of resveratrol and vitamin E on CBZ induced hematological changes of Wistar rats.

Material and Methods

This research work was carried out at the department of human physiology, Ahmadu Bello University Zaria.

Chemicals and Reagents

Vitamin E (Greenbrier International, INC. USA), Resveratrol (Mega Resveratrol Candlewood Stars Limited), Carboxymethylcellulose, Carbamazepine (Micro Labs Limited. India), Corn oil, Chloroform, Cotton wool, Digital weighing balance, and, Test tubes. All chemicals used for this study were of analytical grade.

Experimental Animals

Twenty five adult male Wistar rats were used for the study. The animals were purchased from the Animal House of the Department of Human Physiology, Faculty of Medicine, Ahmadu Bello University, Zaria. The animals were kept and allowed to acclimatize in standard laboratory cages at the Animal House of the Department of Human Physiology and access to standard animal feed and water ad libitum. The animals were divided into five groups (n=5). All administrations were done orally by gavage for forty five days [4,10]. Experimental protocols were in accordance with the guidelines for animal research, as stated in the NIH guidelines for the care and use of laboratory animals (National Academy of Sciences and National Institute of Health Publications, 2011).

Grouping of Animals

Group I: Rats were treated with distilled water 1ml/kg orally for forty five days.

Group II: Rats were treated with carbamazepine 50mg/kg orally for forty five days [4].

Group III: Rats were treated with carbamazepine 50mg/kg and vitamin E 200mg/kg [10].

Group IV: Rats were treated with carbamazepine 50mg/kg and resveratrol 20mg/kg orally for forty five days [17].

Group V: Rats were treated with carbamazepine 50mg/kg, and co-administration of vitamin E (200mg/kg) and resveratrol (20mg/ kg) orally for forty five days.

Blood Sample Collection and Assessments of Hematological Parameters

The animals were sacrificed 24 hours after last administration. They were anaesthetized by chloroform inhalation in a closed chamber and dissected, and blood samples were collected via cardiac puncture in the laboratory of the Department of Human Physiology. Blood sample (2 ml) was collected into EDTA bottles containing 8 mg of disodium salt of ethylene diamine tetra-acetic acid. This was used for total blood count that include Red Blood Cell (RBC) count, White Blood Cell (WBC) count, Platelet count, Packed Cell Volume (PCV) which were determined according to the method described by [18].

Erythrocytes Osmotic Fragility

Determination of erythrocyte osmotic fragility was based on method described by Faulkner and King [19]. and modified by Oyewale [20]. It is an indirect method of determination of oxidative stress status. Briefly, 1 ml of freshly obtained blood collected into EDTA bottles containing 8 mg of disodium salt of ethylene diamine tetra-acetic acid from each rat was pipette into a set of test tubes containing 0.0, 0.1, 0.3, 0.5, 0.7, 0.9 g/dl of sodium chloride stock solution (pH 7.4). This was followed by careful mixing and incubation for 30 min at room temperature (26-28ᵒC). Thereafter, the test tubes were centrifuged at 800 × g for 10 min using a centrifuge IEC HNSH (Damon/IEC Division, UK). The supernatant was transferred into a glass cuvette. The concentration of haemoglobin in the supernatant was measured colorimetrically by reading the absorbance at a wavelength of 540 nm using a spectrophotometer (Jenwey, 6405, Japan). The percentage haemolysis was calculated using the following formula:

Statistical Analysis

All data generated were expressed as mean ± standard of error mean (Mean ± S.E.M.). The data obtained were analyzed using OneWay Analysis of Variance (ANOVA), followed by Tukey’s post-hoc test to compare the level of significance between groups using SPSS version 20. Values of P<0.05 were considered significant.

Results

Effect of Vitamin E and Resveratrol on Red Blood Cell Count

Figure 1 shows the result of the effect of vitamin E and Resveratrol on RBC counts of male Wistar rats chronically induced with carbamazepine. Treatment with CBZ significantly P< 0.05 decreased RBC counts to 6.85+ 0.28x1012/L in comparison to that of the normal control (8.00+0.19x1012/L). Following treatment with vitamin E, the result showed non-significant decrease in RBC count (6.84+0.26x1012/L) when compared to CBZ treated group, however, treatment with Resveratrol significantly P<0.05 increased RBC count (8.14+0.21.x1012/L) in comparison to CBZ treated group. Co-administration of vitamin E and Resveratrol also showed significant (P<0.05) increase in RBC count (8.53+0.15x1012/L) in comparison to that of CBZ treated group.

Figure 1: Effect of Vitamin E and Resveratrol on Red Blood Cell Count. CNTRL= Control; CBZ= Carbamazepine; VIT E= Vitamin E; RESV= Resveratrol. Superscripts indicate statistical significance (P< 0.05); * and # when compared to CNTRL and CBZ treated group respectively.

Effect of Vitamin E and Resveratrol on Packed Cell Volume

Figure 2 shows the results of the effect of vitamin E and resveratrol on Packed Cell Volume (PCV) in CBZ treated rats. Administration of CBZ revealed highly significant (P<0.01) decrease in PCV (39.08+1.66%) when compared to the normal control (50.04+1.14%). Treatment with vitamin E showed increased PCV (42.40+0.76%) but was not statistically significant when compared to CBZ treated group, however, treatment with resveratrol revealed highly significant (P<0.01) increase in PCV level to 48.88+1.43% in comparison to CBZ treated group. Combination of resveratrol and vitamin E also resulted in significant increase compared to CBZ treated group.

Figure 2: Effect of Vitamin E and Resveratrol on Packed Cell Volume. CNTRL= Control; CBZ= Carbamazepine; VIT E= Vitamin E; RESV= Resveratrol. Superscripts indicate statistical significance (P<0.01); * and # when compared to CNTRL and CBZ treated group respectively.

Effect of Vitamin E and Resveratrol on Platelets Count

Treatment with carbamazepine significantly (P<0.01) decreased platelets count (256.00+12.20x10x9/L) in comparison to that of the normal control (314.00+7.07x109/L) as shown in Figure 3. Treatment with vitamin E and resveratrol revealed significant (P<0.01) increase in platelet count to 323.20 ± 23.83x109/L and 338.20 ± 3.98 x109/L respectively compared to CBZ treated group. Co-administration of vitamin E and resveratrol resulted in highly significant (P<0.01) increase in platelet count (361.80+80.46x109/L) compared to the CBZ treated group.

Figure 3: Effect of Vitamin E and Resveratrol on Platelet count. CNTRL= Control; CBZ= Carbamazepine; VIT E= Vitamin E; RESV= Resveratrol. Superscripts indicate statistical significance (P<0.01); * and # when compared to CNTRL and CBZ treated group respectively.

Effect of Vitamin E and Resveratrol on White Blood Cells Count

There was significant (P<0.01) decrease in WBC of Wistar rats following treatment with carbamazepine (4.20+0.21x109/L) as shown in Figure 4 compared to the normal control group (6.08+0.31x109/L). Treatment with vitamin E and resveratrol resulted in significant increase in WBC counts (4.80 ± 0.41x109/L and 5.32 ± 0.20x109/L) respectively compared to CBZ-treated group. Co-administration of vitamin E and resveratrol showed a significant increase in WBCs count (5.90 ± 0.18 x109/L) in comparison to the CBZ treated group.

Figure 4: Effect of Vitamin E and Resveratrol on White Blood Cell count. CNTRL= Control; CBZ= Carbamazepine; VIT E= Vitamin E; RESV= Resveratrol. Superscripts indicate statistical significance (P<0.01); * and # when compared to CNTRL and CBZ treated group respectively.

Effect of Vitamin E and Resveratrol on Osmotic Fragility

There was a significant increase (P<0.01) in lysis at 0.4% and 0.5% of Nacl concentrations of RBC of the CBZ group compared to the control group as shown in Figure 5. Treatment with resveratrol and in combination with Vit E resulted in significant decrease in lysis of RBC compared to CBZ-treated group at 0.4% and 0.6%. respectively.

Figure 5: Effect of Vitamin E and Resveratrol on osmotic fragility. CNTRL= Control; CMC= Carboxymethylcellulose; CBZ= Carbamazepine; VIT E= Vitamin E; RESV= Resveratrol. Superscripts indicate statistical significance (P<0.01); * and # when compared to CNTRL and CBZ treated group respectively.

Discussion

Numerous studies have examined and found that carbamazepine induces oxidative stress, possibly via the formation of free radicals and Reactive Oxygen Species (ROS) thereby decreasing the levels of superoxide dismutase, catalase, and glutathione peroxidase, whereas it increased lipid peroxidation [4]. Oxidative stress significantly reduce total red blood cells, hemoglobin, total white blood cells including neutrophils, platelets and packed cell volume [4]. Continuous exposure to ROS renders erythrocyte sensitive to redox imbalance which in in turn increase OF due to ROS induced changes in the molecular properties of the erythrocyte [21].

In the present study, treatment of Wistar rats with CBZ significantly decreased RBC counts, PCV, PLT and WBC count compared to the normal control group. We have previously shown that CBZ can induce oxidative damage by increasing lipid peroxidation after 45 days administration [22]. The decrease in hematological parameters may be attributed to the fact that carbamazepine undergoes oxidative metabolism which result in the formation of a toxic arene oxide as an intermediate product. The oxide covalently binds with cell macromolecules causing bone marrow toxicity and aplastic anaemia [23]. Carbamazepine induced lipid peroxidation of the lipid bi-layer of cells results in subsequent compromise of cellular membrane integrity. These findings also corroborate the works of [4] who reported that carbamazepine produced a marked decrease in hemoglobin, total erythrocyte count, total leucocyte count, differential leucocyte count, platelet count and packed cell volume.

Following treatment with vitamin E, the result showed a decrease in RBC count, but an increase in PCV and WBC count though not statistically significant when compared to CBZ treated group. However, there was significant increase in PLT compared to CBZ treated group. The non-significant decrease in RBC count may be associated with low dose of Vitamin E. The increase in PCV, PLT and WBC may be due ability of Vitamin E to scavenge lipid peroxyl radicals leading to decrease in lipid peroxidation. Treatment with resveratrol significantly increased RBC, PCV, PLT and non-significant increase in WBC counts, in comparison to CBZ treated group. This could be due to ability of Resveratrol to activate PARP 1 and this stimulate network of genes that protect cells from oxidative-induced damage [24]. This result is in agreement with Nurgül et al., [25] who investigated the protective effects of resveratrol on hematological and biochemical changes in rats induced by sodium fluoride and they found out that hematological changes were ameliorated in the group that received fluoride and resveratrol. However it is contrary to the findings of Juan et al. [16] which showed non alteration of hematological parameters following a high-dose of resveratrol administration. Furthermore, co-adminstration of Vitamin E and Resveratrol significantly increased RBC, PCV, WBC count and decreased OF in comparison to that of CBZ, RESV and VIT E treated groups respectively. The antioxidant activities of both Vitamin E and Resveratrol may have synergistically contributed in the obliteration of lipid peroxidation to reduce oxidative stress as well as the destruction of the blood cells. This result is in agreement with Alhassan et al. [26] who reported that co- administration of antioxidants showed an improvement in packed cell volume, hemoglobin concentration and red blood cell in rats subjected to heat stress. The result may imply that combination of resveratrol and vitamin E may have better synergistic effect during administration.

Red blood cells are distinctive, highly specialized and the most abundant cells in humans and contain high levels of both enzymatic and non-enzymatic cytoplasmic antioxidants [27]. They are the first cells in the body to be exposed to stressful stimuli and hence, prone to oxidative stress [27]. Because of its role as O2 and CO2 transporter, the erythrocytes are under constant exposure to Reactive Oxygen Species (ROS) and oxidative stress [28] The results of the present study showed a significantly increased erythrocyte osmotic fragility were recorded at 0.4, and 0.5 % of Nacl concentrations in CBZ treated groups compared to normal and resveratrol treated as well as the vitamin E treated group. This result could be due to the pro-action of CBZ on ROS level thereby resulting in lipid peroxidation of the membrane lipid bi-layers which are rich in polyunsaturated fatty acids side chains. The decrease observed in the resveratrol treated and vitamin E could have been from the antioxidant activity of the substances which enables them to mop up the prevalent reactive oxygen species, resulting in less damage to the cell membrane of the erythrocytes.

Conclusion

Co administration of resveratrol and Vitamin E exhibited a better protective effect on CBZ induced hematological changes of Wistar rats in a chronic study, more than when resveratrol and vitamin E are administered singly.

Acknowledgement

I thank Almighty Allah who is the author of life, wisdom and understanding for His grace, strength and success of this research work. I am grateful to all of those with whom I have had the pleasure to work during this research.

More BJSTR Articles: https://biomedres01.blogspot.com/